BioMab, Inc. discovers and develops cutting edge immune-based diagnostics and therapeutics to enable healthcare professionals provide patients with personalized care. The company was founded through close collaboration with a leading research group specializing in the field of antibody technologies and targeted therapy at Academia Sinica.
BioMab aims to become a world leader and innovator in immune-based diagnostic solutions and targeted therapeutics for patients worldwide. The company’s products have gained recognition from leading research institutes and has partnered with top 10 global pharmaceuticals, clinics and biotech companies worldwide.
Our mission is to improve human health through innovations.